'Our lungs are highly complex organs that are exquisitely specialized for gas exchange and host defense.' Rawlins (2010) 1. Introduction
Introduction

General considerations
The most important function of the lung is to acquire molecular oxygen and eliminate carbon dioxide. Except probably for the gastrointestinal system, no other organ in the body interacts with the external environment as constantly and as intimately as the respiratory system. For example, during a 24 hour period, at rest, the human lung is ventilated ~25,000 times with ~20,000 L of air (e.g. Burri, 1985; Brain, 1996) , it has a respiratory surface area (RSA) of ~140 m 2 (about the size of a tennis court) which is located in the acini that lie no more than 40 to 50 cm from the external environment (air) (e.g. Weibel, 1984) , and the thickness of the blood-gas (tissue) barrier (BGB) (harmonic mean thickness, ht) is 0.62 μm, a value about one-fiftieth of the thickness of a foolscap paper or that of a human head hair (Gehr et al., 1978 (Gehr et al., , 1990a . By weight, each day, more than 20 kg of air enters and leaves the human body, a load that far exceeds that of food and water ingested during the same time period (Brain, 1996) . Depending on the level of air pollution, different types and quantities of foreign particulates and microbial pathogens are inhaled. While large RSA and thin BGB increase gas exchange, the concomitant downside to these structural properties is that they make the lung a leading portal of entry and therefore attack by pathogenic micro-organisms, damage by allergens and particulates, and injury by noxious gases (e.g. Brain, , 1992 Lambrecht et al. 2001; Garn et al., 2006) . The inhaled particulates are deposited on the epithelial lining of the conducting airways and that of the peripheral air spaces where they are retained for various durations before they are removed or destroyed (e.g. Geiser et al., 1988; Gehr et al., 1990 a, b) . Brain (1996) observed that 'the lung is unique in that the marriage between environment and lung disease is profound. The respiratory system threfore forms a huge challenge to the body's immune integrity (e.g. von Garnier and Nicod, 2009 ).
According to the United Nations Environmental Program (UNEP) and the WHO Report of 1994 (UNEP-WHO, 1994 , annual averages of 600 mg/cm 3 and peak concentrations that may exceed 1,000 mg/cm 3 of solid particles occur in the air that covers many of the world's large metropolis. The frequency and severity of respiratory diseases that arise from inhalation of airborne particles are on the increase (e.g. EPS, 1996; Peters et al., 1997; Wichman and Peters, 2000; Warheit et al., 2009) . Epidemiological studies have shown that even moderate inhalation of particulates, especially those of a diameter <10μm (PM 10 ), cause high morbidity and mortality not only from respiratory but also from cardiovascular diseases, especially in individuals with pre-existing medical conditions (e.g. Dockery et al., 1993; Schwartz, 1994; Brunekreef et al., 1995; Ware, 2000; Pope, 2000; Nemmar et al., 2002; Pope et al., 2002; Suwa et al., 2002; Schulz et al., 2005; Kaufman, 2010; Brook et al., 2010; van den Hooven et al., 2011; Kampfrath et al., 2011) . PM 2.5 cause airway inflammation that presents in form of influx of committed monocytes, even in healthy individuals (Schaumann et al., 2004) . Pulmonary afflictions and diseases have considerable socioeconomic impact. For example, in the United Kingdom, in 2006 more people died from respiratory diseases than from coronary disease or cancer and the cost to the National Health Service (NHS) was over £6.6 billion (BTS, 2006) . According to the National Institutes of Health (NIH), in the United States, people suffer an average 1 billion colds per year and in 2006 the country spent more than 3 billion dollars to investigate respiratory-related diseases (http://www3.niaid.nih.gov/topics/commonCold/). Over 10% of hospitalizations and in excess of 16% of deaths in Canada are attributed to respiratory diseases (http://www.phac-aspc.gc.ca/ccdpc-cpcmc/crdmrc/facts_gen_e.html). According to the Canadian Lung Association (CLA), the economic burden of respiratory disease in the Country is ~3 billion ($US) dollars (http://www.bukisa.com/articles/455926_lung-health-occupational-healthincidence#ixzz1I4jwMvBX). Based on net changes in gross domestic product (GDP) growth forecasts, the estimated annual cost of SARS (Sudden Avian Respiratory Syndrome) in Asia exceeds 10 billion dollars ($US) (Lee and McKibbin, 2003; Fan, 2003; McKibbin and Sidorenko, 2006) and according to the World Bank's estimates, an influenza pandemic may result in a loss (expenditure) of 800 billion dollars ($US) (Brahmbhatt, 2005) : each year, seasonal influenza affects 5%-15% of the population in the northern hemisphere, with some some 3-5 million infections worldwide requiring hospitalization or leading to death (Sanders et al., 2011 ; http://www.euro.who.int/en/what-wedo/health-topics/diseases-and-conditions/influenza/seasonal-influenza 2010). For poultry, an important relatively more affordable source of animal protein, worldwide losses from respiratory diseases are estimated to cost the broiler industry over 1 billion dollars ($US) annually (e.g. Dekich, 1997; Currie, 1999; Wideman, 2005) . Because avian species form an important reservoir of human infections, it is vital to study and understand avian toll-like receptors and related recetors so as to both design vaccine adjuvants and substitutes to the widespread application of antibiotics and in selection of strains of birds with augmented pathogen resistance.
By exerting direct selective pressure and evolving novel strategies of evading and surviving host defences (e.g. Litman et al., 1993; DuPasquier, 1993; Bartl et al., 1994; Beck and Habicht, 1996; Spurgin and Richardson, 2010; Finlay and Buckner, 2011) , microbial pathogens have directly and indirectly fundamentally shaped the genetic and the phenotypic diversity of life. One of the most complex and astounding biological designs -the immune system -by and dendritic cells. On activation by an antigen, phagocytes release and/or react to a group of highly specialized molecular signals called cytokines, e.g., interferons, interleukins (e.g. IL-1 and IL-6), and tumour necrosis factor (TNF) (e.g. Beck and Habicht, 1991; Gerlach et al., 2011) . They also recognize and usually eliminate 'altered self', i.e., cells or tissues that have died, commonly by programmed cell death (apoptosis) or have changed by injury or disease like cancer. Fig. 1 . The sterility of the lung is maintained by complex and efficient interplay of innate-(cellular) and acquired immune factors/systems. Pathogens and particulates that gain enty into it are neutralized, removed or sequestered.
Macrophages form an important part of the innate immune system that comprises of a group of cells that instantly defend the host from infection in a non-specific (generic) manner. In contrast to acquired immunity, macrophages don't confer long-lasting or protective immunity to the host. The common strategies by which bacteria become pathogens were comprehensively reviewed by Finlay and Falkow (1997) . It is evident that pathogenic bacteria evolved from related non-pathogenic microorganisms by genetically gaining relatively large parts of genetic material that encode for virulence factors rather than by slow, adaptive evolution of pre-existing genes (e.g. Blum et al., 1994 Blum et al., , 1995 Lee, 1996; Cheetham and Katz, 1995; Finlay and Falkow, 1997) and that the relentless nature of the challenge (selective pressure) posed by pathogens on animals (and even on plants) affected Fig. 2 . Cellular defences of the respiratory system. Consistent with its high exposure to particulate matter and pathogenic microorganisms, the lung is very well-protected by various populations of phagocytic cells. Depending on need and circumstances, the cells can transfer from one compartment to another.
Among the cellular defences of the respiratory system, at the gas exchange level, pulmonary surface macrophages (PSMs) form the frontline defence of the lung. Highly specialized cells, macrophages clear dead host cells while defending against infection by broad range of pathogen-recognition receptor and their ability to produce inflammatory cytokines and chemokines that control the replication of the invaders (e.g. Gordon, 2002; Hazlett and Wu, 2011) . Macrophages are highly specialized, robust motile cells that belong to a range of subpopulations: in different forms and locations, they display different behaviours and functions (e.g. Bowden, 1976; Dougherty and McBride, 1984; Lehnert, 1992; Brain, 1992; Gordon, 2002; Gordon and Taylor, 2005; Geissmann et al., 2010a, b; Schneberger et al., 2011) . By detecting injurious agents, phagocytosing them, and acting as effector cells for both humoral and cell-mediated immune responses, macrophages serve as the frontline innate defence cells of the lung and as sentinels of the immune system of the body (e.g. Fels and Cohn, 1986; Peão et al., 1993; Warheit and Hartsky, 1993; Yamaya et al., 1995; Rubovitch et al., 2007) . A relationship exists between the numbers of PSMs [like the alveolar macrophages (AMs)] with the level of environmental pollution (Brain, 1971 (Brain, , 1987 Nagdeve, 2004; Sichletidis et al., 2005; Mateen and Brook, 2011; Conklin, 2011) . Even with an elegant defence inventory, respiratory diseases, especially those caused by air pollution, are on the increase (e.g. Peters et al., 1997; Mateen and Brook, 2011; Conklin, 2011) . After the particles or pathogens have eluded or overwhelmed the epithelial barrier of the upper airways, they come into contact with the dedicated antigen presenting dendritic cells (DCs) (e.g. Steinman and Cohn, 1973; Nicod, 1997; Lipscomb and Masten, 2002; Holt, 2005) which are highly phagocytic Kiama et al., 2001 Kiama et al., , 2006 Walter et al., 2001) . If they reach the alveolar surface, they are dealt with by the PSMs (e.g. Bowden, 1976; Goldstein and Bartlema, 1977; Geiser, 2002) .
While macrophages are central to the defence of the lung from assaults by injurious materials and pathogenic agents (e.g. Holt et al., 1982; Weissler et al., 1986) , their roles extend beyond engulfing (phagocytosing) and neutralizing harmful agents. They are secretory and regulatory and control activities of other cells like neutrophils, lymphocytes, and fibroblasts (e.g. Adamson and Bowden, 1981) . Contrary to their well-serving protective activities, under certain conditions, macrophages function as a 'double-edged sword': they can initiate, exacerbate, and prolong inflammatory responses that cause immune suppression and progression of pathologies like cancer, leading to higher morbidity and mortality (e.g. Brain, 1976 Brain, , 1980 Brain, , 1992 Brain et al., 1984; Bowden, 1987; Warner, 1996; Yanagawa et al., 1996; Fireman et al., 1999; Ishii et al., 2005; Parbhakar et al., 2005; Rubovitch et al., 2007; Shimotakahara et al., 2007; Sica and Bronte, 2007; Kaczmarek et al., 2008; Gill et al., 2008; Biswas et al., 2008; Aharonson-Raz and Singh, 2010; De Palma and Lewis, 2011) .
In spite of their widely accepted common origin from the bone marrow, their hematogenetic origin (e.g. Brain, 1976 van Furth, 1982; Geiser, 2010) , macrophages display great phenotypic and functional heterogeneity (Krombach et al., 1977; Nguyen et al., 1982; Lehnert, 1992; Warheit and Hartsky, 1993; Kiama et al., 2008) . Local environments largely determine the structural and functional differences (e.g. Morrissette et al., 1999) . Within and between animal species, the immune reactions, phagocytic competences, and the cytoenzymological properties of different groups of macrophages have been shown to be spatially compartmentalized: observations made on one population of macrophages may therefore not correctly apply to another. For example, the AMs have slower rate of phagocytosis, higher motility, and faster particle clearance compared to the pulmonary intervascular macrophages (PIVMs) (Molina and Brain, 2007) . Compared to the human ones, the dog's AMs have relatively less cytoplamic motility when acutely exposed to cigarette smoke (Yamaya et al., 1989) and during acute asthmatic attack (Yamaya et al., 1990) . Among rodents, the AMs of the rat lung are the most efficient in clearing inhaled iron particles while the hamster ones are recruited to the site of particle deposition by noncomplement-mediated mechanism (Warheit and Hartsky, 1993) while the hamster and guinea pig's AMs best respond to bacteria (Warheit et al., 1988) . Compared to those of the rat, the PSMs of the bird lung phagocytose polystylene particles more efficiently (Kiama et al., 2008) .
The term 'pulmonary macrophage' (PM) loosely refers to cells that occupy two anatomical compartments of the lung: in the upper airways are the bronchial macrophages (BMs) and in the lower respiratory tract are the surface (free) macrophages (SMs) (e.g. Crowell et al., 1992) . Other groups of phagocytes, however, exist in other parts of the lung. These are the dendritic cells (DCs), the pleural macrophages (PlMs), the pulmonary interstitial macrophages (PIMs), and in the lungs of certain species of animals the pulmonary intravascular macrophages (PIVMs). The structural attributes and the functional roles of these groups of cells are succinctly described below. To the best of my knowledge, this is the first comprehensive review of the biology of the PMs from a comparative perspective.
Pulmonary surface (free) macrophages (PSMs)
Acting as scavengers on the respiratory surface, the highly motile PSMs phagocytose, neutralize, and sequester harmful foreign materials (e.g. Sibille and Reynolds, 1990; Kelley, 1990; Lohmann-Matthes et al., 1994; Steinmüller et al., 2000) . Also, by having receptor sites for immunoglobulins and complement on their cell membranes, PSMs contribute to the health of the lung by passing on specific information to immunologically competent cells like neutrophils, lymphocytes, and plasma cells, in so doing promoting antigen-antibody response (e.g. Said and Foda, 1989; Ooi et al., 1994) . PSMs appear to stimulate and promote repair of epithelial cells after injury by releasing a growth factor (e.g. Takizawa et al., 1990) . Interaction between PSMs and bronchial epithelial cells (BECs) during exposure to particulates with a diameter of less than 10 μm (PM 10 ) contributes to production of mediators (molecular factors) that induce a systematic inflammatory response (e.g. Hirano, 1996; Fujii et al., 2002; Ishii et al., 2005; Rubovitch et al., 2007) .
Large, mononuclear cells, PSMs consist of several subtypes that can be categorized by criteria like size, morphology, numbers, motility, ingestion and handling of foreign materials, adherence onto surfaces, and expression of surface receptors (e.g. Brain, 1976 Brain, , 1980 Brain, , 1992 Zwilling et al., 1982; Nguyen et al., 1982; Holt et al., 1982; Warheit et al., 1984 Warheit et al., , 1986 Sebring and Lehnert, 1992; Spiteri et al., 1992; Lavnikova et al., 1993; Johansson et al., 1997) . The existence of subpopulations of macrophages that have functionally distinct roles in airway immunity derives from the individual bone marrow precursor cells and the environment that they reside in (Gant and Hamblin 1985) . Compared to the PIVMs, the rat PSMs exhibit marked microbial activity through high production of reactive oxygen species (ROS), nitric oxide (NO), and tumour necrotic factor-(TNF-) (Steinmüller et al., 2000) . Exposure of rats to NO induces infiltration of AMs that are phenotypically and functionally different (regarding mediator mRNA expression and production as well as mRNA expression for several matrix metalloproteinases) from the resident AMs (Garn et al., 2006) . Ensuing from infection or overwhelming by irritants, need for more macrophages is met by in situ replication of existing cells, release of pre-existing cells from various compartments (reservoirs) within the lung, increased production from macrophage precursors in the lung interstitium, and increased flux of monocytes from blood to the lung (e.g. Brain, 1980 Brain, , 1992 . The PSMs are renewed at a rate of ~1-2% of the total number of cells in the lung (e.g. Shellito et al., 1987) daily. The temporal sequence of particle clearance by phagocytes entails particle identification, endocytosis, and transport from the alveolar surface (Green, 1973 (Green, , 1984 Warheit et al., 1984) . Resting freely on the respiratory surface, PSMs are directly exposed to particulates, . Stars, filopodia (feet); Er, erythrocyte; asterisks, lysosomes; Nu, nucleus; Ep, epithelial cell. Scale bars: Figs. 3, 30 μm; 4, 45 μm; 5, 30 μm; 6, 50 μm; 7, 10 μm; 8, 25 μm; 9, 10 μm; 10, 10 μm; 11, 10 μm; 12, 15, μm; 13, 20 μm; 14, 10 μm.
environmental toxicants, and pathogens. In contrast to fixed or interstitial macrophages that are attached to the collagenous fibers of the tissue matrix, they (PSMs) actively move over the respiratory surface by ameboid movement that entails formation of deformations of the cell membrane, leading to cytoplasmic extensions (advancing lamella = filopodia = pseudopodia) in the direction of the movement, pulling the main part of the cell with it (Figs. 10, 11, 13, 14) . Actin-binding protein and myosin advance in the tips of the filopodia (Reaven and Axline, 1973; Stossel and Hartwig, 1976; Hartwig et al., 1977) . In addition to effecting movement, formation of filopodial extensions by contractile proteins is involved in phagocytosis of foreign agents (Stossel, 1978; Zigmond and Hirsch, 1979) . Cytoplasmic motility corresponds with phagocytic activity of PSMs: both cytoplasmic movement and phagocytosis may be regulated by similar mechanism in the cytoskeletal system (Yamaya et al., 1995) . Once the phagocytosed particle is engulfed, i.e., is enclosed within the invaginated cell membrane and transferred to a cytoplasmic location, it is called a phagosome.
Macrophages are chemotactically driven to foreign materials/agents. The terms 'free', 'wandering', and 'fixed' macrophages refer to different functional states and/or stages of the development of cells of same cell phagocytic lineage. When stimulated, fixed macrophages detach from collagenous fibers and migrate as free macrophages to sites of pathogen invasion, injury, or irritation. PSMs remain motile up to a certain particle loading and beyond that the mobility is greatly inhibited (e.g. Yu et al., 1989; Lehnert et al., 1990; Kiama et al., 2008) . For the avian PSMs (Kiama et al., 2008) , the cells burst after ingesting high loads of polystylene particles . Inability of dust-laden AMs to reach the mucociliary escalator system of the upper airways correlates with the particle loading (Morrow, 1988) . In the Fischer 344 rat, when the loading exceeds ~600 μm 3 per cell, particle clearance ceases and the particle laden cells remain in the alveolar region. Interestingly, PSMs can be overwhelmed by even small amounts of ingested particulates, e.g., carbon particles (concentration 0.2 μm.10 -6 ) and also by long term (22-44 hr) incubation with low concentrations (12.5 M.ml -1 ) of interferon-(IFN-) (Lundborg et al., 1999 . PSMs may also be rendered non-functional by exposure to inordinately high concentration of particulates or pathogens, especially where there are underlying infections that invoke increase in production of IFN- (Baron et al., 1991; Cuffs et al., 1997; Camner et al., 2002) . The ultrastructural morphology of the AMs has been well-documented (e.g. Weibel, 1984 Weibel, , 1985 . Remarkably heteromorphic, they vary in size from 10 to 40 μm in diameter, constitute 2 to 9% of the pneumocytes, and have an indented (bean = horse shoe-shaped) eccentrically located nucleus (e.g. Sebring and Lehnert, 1992; Weibel, 1984 Weibel, , 1985 (Fig. 12) . The nuclear indentation contains numerous vacuoles, Golgi apparati, rough endoplasmic reticulum, and mitochondria. The most striking structural features of the PSMs are the large number of membrane bound cytoplasmic inclusions that include lysosomes, phagososmes, vacuoles, and lipid droplets (Figs. 7, 11, 12 and are oblong or spherical in shape. They contain high concentrations of various strong hydrolytic enzymes which are synthesized in the rough endoplasmic reticulum and packaged in the Golgi complex, forming the primary lysosomes. When the primary lysosomes combine with the phagosomes, they form the secondary lysosomes. The brokendown/detoxified foreign agents are either discharged from the cell or are stored in membrane bound granules called residual bodies. The foreign indigestible materials, e.g., carbon-and heavy metal particles, are sometimes permanently stored in the phagocytic cells of the lung. When macrophages are overwhelmed by large foreign materials that cannot be efficiently phagocytosed by individual cells, they form multinucleated giant cells that sequester such factors. Nodular inflammatory lesions that contain these cells are termed granulomas (e.g. Fawcett, 1986) .
Although different views have been expressed by, e.g., Sorokin et al. (1984) , it is now widely accepted that PSMs do not form in situ, i.e., in the lung: they belong to the general mononuclear phagocyte (formerly reticuloendothelial) system of the body and originate from stem cells in the bone marrow from where they are transported in blood as monocytes. On entering the interstitium of the lung they undergo a series of maturational stages before transferring to the surface (e.g. van Furth, 1970; Bowden and Adamson, 1980; Blussé van Oud Alblas et al., 1983; Bowden, 1987; Sebring and Lehnert, 1992; Brain et al., 1999; Geiser, 2010) . The turnover time of the PSMs is ~6 days and amounts to 15.10 3 cells per hour (Blussé van Oud Alblas et al., 1983) . The fate of PSMs is varied: a) many of the cells leave the peripheral air spaces via the bronchi where they are transported by the mucociliary escalator system to the oral pharynx (e.g. Spritzer et al., 1968) to be swallowed or expectorated; b) others move to the interstitium and either settle there or leave via the lymphatics (e.g. Sorokin and Brain, 1975) . Compared to the PIMs, AMs have greater phagocytic activity and faster attachment and ingestion properties (Franke-Ullmann et al., 1996; Fathi et al., 2001 ).
While pulmonary cellular defence appears to exist in the amphibian-(e.g. Welsch, 1981 Welsch, , 1983 Maina and Maloiy, 1988; Maina, 1989) (Figs. 13, 14) and reptilian lungs (Grant et al., 1981) , PSMs are rare in the lungs of the lower vertebrates (Bargmann, 1936) . Welsch (1983) experimentally stimulated a macrophagic response in the lung of Xenopus laevis after exposure and aspiration of carbon particles. In the caecilian lung, macrophages contain acid phosphatase, -glucosaminidae, and unspecific esterase (Welsch, 1981) . In the lungs of the lower vertebrates (Welsch and Müller 1980) , epithelial cells (pneumocytes) contain acid phosphatase and have a phagocytic capacity. No resident surface macrophages occur in a nonchallenged lung of the snake, Boa constrictor (Grant et al., 1981) : unphagocytosed materials remained on the respiratoty surface for up to 4 days. Challenge of the snake lung with inspirable particles increases surfactant secretion, elicits surfacing of nonphagocytic eosinophilic granulocytes, but interestingly doesn't set off release of mononuclear phagocytic macrophages (Grant et al., 1981) .
While the biology of the AMs has been well-studied (e.g. Bowden, 1987) , relatively little is known about the SMs of the avian respiratory system. Paucity of SMs (e.g. Stearns et al., 1986; Toth et al., 1988; Klika et al., 1996; Maina and Cowley, 1998; Nganpiep and Maina, 2002; Kiama et al., 2008) and even lack of them was reported by, e.g., Lorz and López (1997) . In mice, rats, and guinea pigs, respectively, yields of 0.55-1.55.10 6 , 2.86-4.43.10 6 , and 1.08-1.77.10 7 AMs were determined by Holt (1979) . Some of these values are 20 times greater than those determined in much larger birds (e.g. Toth and Siegel, 1986) . The average number of SMs in the lung of the pigeon, Columba livia is 1.6.10 5 (Maina and Cowley, 1998) , in the domestic fowl, Gallus gallus variant domesticus it is 2.5.10 5 (Toth and Siegel, 1986; Toth et al., 1987) , and in the turkey, Meleagris gallopavo is 1.15.10 6 (Ficken et al., 1986) . The number of SMs per unit body mass in the rat was significantly greater than that of the domestic fowl and the duck, Cairina moschata (Nganpiep and Maina 2002) (Fig. 18) . In a 30 year-old smoker and a nonsmoker, respectively, 1.5.10 7 and 5.2.10 7 AMs were harvested by bronchopulmonary lavage by Hof et al. (1990) . Regarding cellular defence strategies, mechanisms, and proficiencies, it has been contended by different investigators, e.g., Klika et al. (1996) and Spira (1996) that compared to mammals, birds are relatively more susceptible to pulmonary diseases and afflictions. In the poultry industry, huge economical losses have been ascribed to mortalities arising from respiratory diseases (e.g. Mensah and Brain, 1982; Toth et al., 1988) . Scarcity of SMs in the avian lung (e.g. Stearns et al., 1986; Maina and Cowley, 1998; Nganpiep and Maina, 2002; Kiama et al., 2008) and enzymatic deficiencies in the oxidative metabolism of the SMs (e.g. Penniall and Spitznagel, 1975; Bellavite et al., 1977) have been reported. Fig. 18 . Comparison between the numbers of pulmonary surface macrophages (PSMs) in the chicken (domestic fowl) (Gallus domesticus), the rat (Rattus rattus), and the duck (Cairina moschata). Birds have relatively fewer PMS compared to mammals. From Nganpiep and Maina (2002) .
The foremost morphological and physiological factors that may predispose the avian respiratory system to injury by inspired foreign agents are: a) a relatively thin BGB and extensive RSA (e.g. Maina et al., 1989) , b) large tidal volume and continuous and unidirectional ventilation of the lung (e.g. Fedde 1980 Fedde , 1997 Brown et al., 1997) , and c) in some species, e.g., the ostrich, Struthio camelus (Bezuidenhout et al., 2000) , the air sacs extend out of the coelomic cavity to lie subcutaneously, where they are highly susceptible to trauma and infection: in such cases, air sacculitis (infection of the air sacs) can easily spread to the lung.Categorical proof that the avian lung is relatively more susceptible to infection by inhaled biological pathogens is lacking. It was argued by Maina (2005) that in the bird lung, PSMs, cells that are abundantly endowed with lysosomes (Nganpiep and Maina 2002) (Fig.  19-24 ) and have greater motility and phagocytic capacity (Kiama et al., 2008 ) may be so efficient that only few of them are required to reside on the respiratory surface and provide adequate protection. Pulmonary cellular defence is reinforced by capacity of rapidly mobilizing and transferring PIMs, PIVMs and probably blood monocytes to the respiratory surface (Nganpiep and Maina, 2002) . Under similar conditions, birds may not be any more susceptible to pulmonary diseases than mammals. Factors like extreme genetic manipulation for faster growth and weight gain and the intensive and stressful regimes of battery production and management may explain the high incidence of aerosol transmitted pulmonary diseases, particularly in poultry.
Pulmonary interstitial (subepithelial) macrophages (PIMs)
Mainly because they are relatively less accessible, compared to the PSMs which are easily harvested by pulmonary lavage (e.g. Holt et al., 1985; Steinmüller et al., 2000) , the PIMs have been relatively less well-studied. They are found in the peribronchial and perivascular spaces, in the interstitial spaces of the lung parenchyma (Fig. 25) , in the lymphatic channels, and in the visceral pleural region (e.g. Bedoret et al., 2009; Nganpiep and Maina, 2002) . Occurring in substantial numbers, PIMs provide bactericidal and immune mediated protection against particles and pathogens that escape the PSMs and penetrate the epithelium: there, they are sequestered or removed via the lymphatic channels. In the rat lung, PIMs form a substantial fraction of the PMs (e.g. Sebring and Lehnert, 1992) : they comprise from 37% to 40% of the PMs (Lehnert et al., 1985; Crowell et al., 1992) . However, using a different method, Blussé van Oud Alblas and van Furth (1979) determined that PIMs form only 7% of the PMs in the mouse-, rat-, and hamster lungs. In normal and injured lungs, PIMs exceed the number of PSMs (e.g. Thet et al., 1983) .
Phenotypical and functional differences occur between the PIMs and the PSMs: PIMs are smaller in diameter (7.6 μm versus 16 μm for the PSMs), are more homogenous in size, have a smoother outline [i.e., they have fewer and blunter filopodia (pseudopodia)], have an indented (kidney-shaped) nucleus and greater nuclear to cytoplasm ratio, the primary lysosomes and phagososmes are fewer and larger, mitochondria and rough (granular) endoplasmic reticulum are scanty, Golgi bodies are rare, the cells are less phagocytic, they possess greater antigen presenting capability to T-cells, when they are activated they can release different cytokines [particularly TGF-, TNF-, and metalloproteinases-1 (MCP-1) and IGF-1], and the cells resemble the peripheral monocytes (e.g. Kobzik et al., 1988; Sebring and Lehnert, 1992; Lavnikova et al., 1993; Wizemann and Laskin, 1994; Prokhorova et al., 1994; Johansson et al., 1997; Fathi et al., 2001 ). Antigenic differences occur between the PIMs and the PSMs (e.g. Kobzik et al., 1986) . In the rat lung, regarding the mechanisms that are mainly involved in the induction and the furtherance of specific immune reactions, e.g., the major histocompartibility complex (MHC) class-II expression and interleukin (IL-1) and IL-6 production, the PIMs are more efficient than the PSMs (Steinmüller et al., 2000) . Since they are set in the lung tissue, the cytotoxic or inflammatory mediators released by the PIMs have greater biological and/or pathological effects on the surrounding lung tissue than those released by the PSMs (Steinmüller et al., 2000; Laskin et al., 2001 ). In the murine lung, PIMs exhibit immunoregulatory and phagocytic functions (e.g. Bilyk et al., 1988; Franke-Ullman et al., 1996) . Increased numbers of PIMs appear within active lesions of the injured lung (e.g. Brain, 1988) . There is ample evidence that PIMs replicate in situ (e.g. Bowden and Adamson, 1980) . Compared to the PSMs, the PIMs exhibit a significantly greater proliferative capacity (Johansson et al., 1997) , a process that maintains the lung macrophage pool in the lung tissue compartment (Adamson and Bowden, 1981) .
The PIMs can be discriminated from the PSMs by their unique capacity of inhibiting the maturation of the lung's DCs and their migration on stimulation with lipopolysaccharides (LPS) like those located in the outer membrane of gram positive bacteria which act as endotoxins that elicit strong immune responses that prevent sensitization to prevailing antigens (e.g. Buckner and Finlay, 2011) . In presence of LPS, PIMs and not PSMs disrupt the link between the innate and the adaptive immunity, allowing inhaled antigens to escape from T-cell dependent responses (e.g. Bedoret et al., 2009 ). The PIMs are morphologically more like the BMs than they are to PSMs (Sebring and Lehnert, 1992) . It has been suggested by some investigators, e.g., Holt et al. (1982) , Bluseé van Oud Alblas and van Furth (1982) , and Sebring and Lehnert (1992) that PIMs are an intermediate maturation stage (from the bone marrow monocytes) of the PSMs, i.e., they are precursors of the PSMs before the cells transfer to the respiratory surface. There is, however, contrary evidence that PIMs represent a distinct population of cells with dedicated pulmonary inflammatory and immunoregulatory roles of defending the lung (e.g. Chandler et al., 1988; Dethloff and Lehnert, 1988; Lehnert, 1992; Prokhorova et al., 1994; Johansson et al., 1997; Zetterberg et al., 1998; Steinmüller et al., 2000) . Although concerning inflammation and antimicrobial defense AMs exhibit greater functional repertoire related to and including increased chemotaxis, phagocytosis, cytotoxicity, and release of ROSs, PIMs express higher quantities of C3-receptor and intercellular adhesion molecule-1 and are more active in producing interleukins-1 and -6 (IL-1 and -6) and exhibit greater I-a antigen expression (Chandler and Brannen, 1990; Franke-Ullmann et al., 1996; Steinmüller et al., 2000) .
Bronchial epithelial cells (BECs) and bronchial macrophages (BMs)
The ciliated BECs and the nonciliated cells of the upper airways of the lung are the first cellular entities that interact and deal with the inhaled particulates and pathogenic microorganisms (Figs. 31-34 ). They secrete inflammatory cytokines that initiate and ultimately aggravate host innate inflammatory responses that may cause harmful immunemediated pathologies (e.g. Yoshikawa et al., 2010) and afterwards initiate remodelling of the lung (Altraja et al., 2009 ). In the bronchial tree, macrophages are suspended in the mucus carpet while others lie under the layer, directly attached onto the epithelial substratum (e.g. Sorokin and Brain, 1975; Brain et al., 1984; von Garnier and Nicod, 2009) (Fig. 34) . A highly active group of cells, ciliated BECs and non-ciliated BECs may ingest and degrade antigens that land on the surface of the airways and/or may release mediators that attract lymphocytes, neutrophils, or mast cells to the airways and regulate their activities there (Geiser et al., 1988) . On their depositing on the airway epithelium, inhaled bacteria soon loose their replicative capacity (e.g. Laurenzi et al., 1964; Brain et al., 1984) . Particulates with a diameter of less than 10 μm (PM 10 ) stimulate epithelial cells to produce ROS and inflammatory mediators/cytokines (Carter et al., 1997; Fujii et al., 2001; Schaumann et al., 2004; Ishii et al., 2005) . In the avian lung, ciliated epithelial cells particularly phagocytose inhaled atmospheric particles (Fedde, 1997; Maina and Cowley, 1998; Fujii et al., 2001; Nganpiep and Maina, 2002) (Figs. 26, 27) . Ciliated BECs express an oxidative stress response that is different from that of the PSMs by rapidly shifting from cytoprotective to cytotoxic responses but are incapable of converting N-acetylcysteine to cytoprotective glutathione (Li et al., 2002) . A mucus escalator system, which is maintained by the motility of cilia (Fig. 34) , transports particulates and pathogens that settle on the airways towards the mouth. Normal motility of cilia is vital to the preservation of the integrity of the mucus conveyer-belt system. Infectious diseases and genetic conditions that reduce or abolish cilia motility, e.g., Kartagener's syndrome (e.g. Mahsud and Din, 2006; Kapur et al., 2009) , and those that increase the consistency (viscosity) of the mucus, e.g., cystic fibrosis (Chmiel and Davis, 2003; McShane et al., 2004) lead to higher incidence of pulmonary infections, as they decrease the removal of particulates and pathogens by the mucus escalator system. According to Fireman et al. (1999) , 'asthma may be defined as failure to regulate T-cell mediated immunoreactivity within the bronchial wall of hyperreactive airways'. Inadequate regulation of the T-cell response by suppressive macrophages may set off allergic bronchial inflammation. The BMs of asthmatics are functionally modulated (e.g. Fireman et al., 1999: they have lower suppressive activity. Probably caused by T-helper cell cytokines (Th-2), this explains the bronchial hyperactivity displayed by asthmatics (Fireman et al., 1999; Alexis et al., 2001) . Different subsets of the BMs may to different extents regulate the inflammatory response in allergic asthma and respond to immunomodulatory signals, especially those mediated by interleukin 10 (IL-10) (Moniuszko et al., 2007) . Power et al. (1994) observed that in normal human bronchial wall, a small number of T-cells, the majority of which were CD8 + cells existed: CD4 + cells predominated in the subepithelial tissue and a small number of macrophages were present. In individuals with sarcoidosis, compared to healthy subjects, Hawley et al. (1979) observed physical interaction between the BMs and the lymphocytes, the BMs presented a more highly irregular cell surface, and more membrane bound inclusions and fewer lysosomes and phagolysosomes were present: no significant differences were observed in the nuclear or cellular diameters of the BMs from normal-and sarcoidosis affected individuals. In patients with chronic obstructive pulmonary disease (COPD), the BMs were relatively small in size, contained little cytoplasm, and had a markedly high kario-cytoplasmic ratio (Fedosenko et al., 2010) : these features improved after treatment with the drug tiotropium. In the bronchial mucosa of patients with chronic bronchitis, there was a significant number of BMs and T-lymphocytes in the lamina propria (Saetta et al., 1993) : these cells may be involved in the pathogenesis of the disease.
Dendritic cells (DCs)
The DCs derive from bone marrow precursor cells and with their maturation, dependent on the extracellular microenvironments establish themselves as immature cells in tissues (e.g. Steinman, 1991; Reid, 1997; Hart, 1997; Banchereau and Steinman, 1998; Austyn 1998; Satthaporn and Eremin, 2001; Lipscomb and Masten, 2002; Geurtsvankessel and Lambrecht, 2008; Fries and Griebel, 2011) . Under appropriate signals, monocytes can differentiate into DCs (e.g. Banchereau and Steinman, 1998; Satthaporn and Eremin, 2001 ) which are potent antigen uptake, processing, and presenting cells (e.g. Belz et al., 2004; Harada et al., 2009; Bedoret et al., 2009) . Highly specialized and notably heterogenous, DCs function as messengers and regulators between innate and acquired immunity (e.g. Reid, 1997; Hart, 1997; Banchereau and Steinman, 1998; Austyn, 1998; Satthaporn and Eremin, 2001; Dzionek et al., 2000; Webb et al., 2005; McKenna et al., 2005; Lommatzsch et al., 2007 Lommatzsch et al., , 2010 GeurtsvanKessel and Lambrecht, 2008; von Garnier and Nicod, 2009) . Because DCs have the ability to induce a primary immune response in resting naïve T-lymphocytes and play a role in the maintenance of B-cell function and antigen memory (recall) responses (e.g. Webb et al., 2005; Bessa et al., 2009) , they were called 'professional antigen presenting cells' by, e.g., Lipscomb and Masten (2002) and Liu (2005) . To better assess incoming antigens for possible threat, mature DCs particularly occur in tissues that interface between the external-and the internal environments and are therefore greatly exposed to microbial pathogens, harmful particulates, and injurious gases. These include the skin, where the cells are called Langerhan's cells [named after Paul Langerhan (1847-1888), a German physician, who first described them in the late 19 th Century], the inner lining of the nose, the lungs, the stomach, and the intestines (e.g. Satthaporn and Eremin, 2001; Sallusto and Lanzavecchia, 2002; von Garnier and Nicod, 2009) . Notable exceptions are the complete absence of the DCs in the cornea and the central nervous system (e.g. Steinman, 1991) . DCs are a major source of many cytokines, e.g., interferon-(IFN-) and the inflammatory protein MIP1g: both of these molecular factors are important in effecting primary immune response (e.g. Zhou and Tedder, 1995; Devergne, 1996) . In the different sites where they are located, DCs differentiate and become active in acquiring and processing antigens. The subsequent presentation on the host cell surface is associated with the major histocompatibility molecules (e.g. Meyer and Mack, 2003) .
The DCs are found in immature form in blood (e.g. Dzionek et al., 2000) (Fig. 35 ) and once they are activated, they migrate to the lymph nodes where they interact with the T-and Bcells to initiate acquired immune response. In the lung, DCs exist in many subpopulations that are fine-tuned to different roles that maintain immune homeostasis. Infectious and inflammatory conditions can profoundly change functions, with steady-state DC subsets resulting in recruitment of inflammatory type DCs (e.g. Geurtsvankessel and Lambrecht, 2008) which exert specific functions that can be associated with distinct expression of endocytotic receptors and cell-surface molecules, and the topographical location in the lung. During DC trafficking into the lung, blood DCs are preferentially recruited over blood monocytes (Klinke, 2006) : for short-lived antigens, lung epithelial DCs that are derived from blood DCs exhibit a 62.5% increase in antigen density compared to those derived from the blood monocytes. The cells (DCs) are located within the bronchial epithelium and the pulmonary interstitium where they impinge on the innate immune system. CD11c-positive DCs are widely distributed in the alveolar region of the lung, with most of them displaying an immature phenotype (Gonzalez-Juarrero and Orme, 2001): the cells are capable of phagocytosing live Mycobacterium tuberculosis bacteria, leading to secretion of interleukin-12 (IL-12) and stimulation of CD4-T cells to produce gamma interferon (IFN-). In steady-state (homeostatic) conditions, fine balance exists between the various functions of lung's DC populations, a feature necessary for the maintaintence of immune homeostasis in the lung (GeurtsvanKessel and Lambrecht, 2008) . On identification and internalization of pathogens, DCs move to the draining lymph nodes of the lung to instigate specific cellular and humoral immune responses. Extensive network of bone marrow-derived DCs exist in the mucosa of the nose and the large conducting airways, the alveolar lumen, and the connective tissue surrounding the blood vessels and the pleura (Holt et al., , 1994 Schon-Hegrad et al., 1991; van Haarst et al., 1994; Lambrecht et al., 1998; Gonzalez-Juarrero and Orme, 2001; von Garnier and Nicod, 2009 ). The migration of the airway DCs in response to an immunogenic stimulus is rapid (e.g. Havenith et al., 1993; Xia et al., 1995) : within 12 hours, the lung derived DCs can be found in the T-cell area of draining mediastinal lymph nodes of the lung. Inflammatory diseases of the human lung are associated with the different phenotypes and the process of the recruitment of the airway DCs (Lommatzsch et al., 2007 (Lommatzsch et al., , 2010 Geurtsvankessel and Lambrecht, 2008; Vassallo et al., 2010) . Regulation of galectin-3 in the lungs may represent one of the multiple potential mechanisms by which galectins contribute to modulation of the innate and acquired immune responses (Maldonado et al., 2011) .
The classical morphology of the DCs, i.e., that of having numerous membranous processes (projections) that extend out of the main cell body (Fig. 35) , makes them highly motile. Also, it endows them with very large surface-to-volume ratio that permits them to contact and therefore adeptly sample (sense) vast parts of the surrounding environment. DCs contain abundant antigen processing organelles that include endosomes, lysosomes, and special granules. From their distinctive projections, the designation 'dendritic cell' was coined by Steinman and Cohn (1973) since the cells (DCs) resemble the dendrites of the neurones, although DCs are not associated with the nervous system and by extension the neuronal dendrites. Depending on species, DCs are classified into myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) (e.g. McKenna et al., 2005; Geurtsvankessel and Lambrecht, 2008; von Garnier and Nicod, 2009) . The former are more common and are divided into an mDC-1 subpopulation which is the foremost stimulator of T-cells and the mDC-2 which are involved in wound healing. Both groups of cells secrete and express TLR-2 and TLR-4 receptors (e.g. Sallusto and Lanzavecchia, 2002) . The pDCs resemble plasma cells but have certain features similar to the mDCs (Vanbervliet et al., 2003; Liu, 2005) : they can produce large amounts of interferon-. The functional specialization and the degree of maturation of the DCs are determined by the tissue environment and the tissue cells that DCs directly interact with (Wu and Liu, 2007) . In the airways, DCs sense incoming airborne antigens by extending their dendrites through the epithelial cells that line the airway lumen (e.g. Jahnsen et al., 2006; Holt et al., 2008) . Under normal (healthy = steady-state) conditions, in the alveolar space, 80% of the cells are PSMs, with the remainder comprising of T-cells and DCs (von Garnier et al., 2005) . In the respiratory tract, resident DCs are deemed to be immature (von Garnier and Nicod, 2009 ). This signifies that the cells have optimal capacity of detecting, capturing, and processing inhaled antigens but have a low capacity of stimulating T-cells. In contrast to the B and T-lymphocytes, DCs have retained many of the pattern recognition receptors and are thus uniquely capable of sensing stimuli such as tissue damage, necrosis, and bacterial and viral infection (Webb et al., 2005; Klinke, 2006) . The capacity of the lung's DCs to influence specific CD-4 and CD-8 T-lymphocytes makes them suitable candidates for vaccine development strategies for treating and preventing conditions and diseases such as allograft rejection responses, allergy, and asthma, as well as autoimmune diseases and cancers (Fong and Engelman, 2000; Syme and Gluck, 2001; Sharma et al., 2003; Schott and Seissler, 2003; Decker et al., 2006; Sbiera et al., 2008) .
Pleural macrophages (PlMs)
The PlMs are one of the pulmonary macrophage cell lineages that have been least studied (e.g. Brain 1992 ). Lehnert (1992) suggested that PlMs originate from peripheral blood monocytes that migrate across the mesothelial lining of the pleura. Meuret et al. (1980) , Zlotnik et al. (1982) and Sestini et al. (1984) observed that PlMs were more morphologically similar to the peritoneal macrophages than to the PSMs. This may be attributed to the prevailing similarities and differences in the prevailing microenvironments (Brain, 1992) like the variation in the PO 2 (Brain 1988) . Frankenberger et al. (2000) noted that PlMs are a unique kind of tissue macrophage. Under normal physiological conditions, the pleural cavity is in a state of negative (subatmospheric) pressure: low oxygen (O 2 ) tension (PO 2 ) prevails in it. Pleural O 2 exposure induces oxidative injury and aggravates latent systemic inflammatory response (Tsukioka et al., 2007) . Resident PlMs sense perturbations in the local environment and initiate neutrophil infiltration (Cailheir et al., 2006) . The drugs carrageenan and tetracycline prompt dramatic increase in PlMs (e.g. Sahn and Potts, 1978; Ackerman et al., 1980; Strange et al., 1989; Baumann et al., 1993) by recruiting monocytes from the peripheral circulation (Antony et al., 1985) . In vivo experiments have demonstrated tumoricidal- (Basic et al., 1979; Nagashima et al., 1987) , phagocytic- (Meuret et al., 1980; Zlotnik et al., 1982; Zlotnik and Crowle, 1982) , and antimicrobial activities of the PlMs (Meuret et al., 1980; Hammerstrom, 1980; Zlotnik and Crowle, 1982) . Compared to PSMs, the cells (PlMs) release prostaglandins E-1 and E-2 and respond differently to various cytokines (Sestini et al., 1984; Nagashima et al., 1987) . Agostini et al. (1972) suggested that PlMs may function as roller bearings that allow smooth movement between the parietal-and the visceral pleura. The PlMs seem to be functionally important in both health and disease (Zlotnik et al., 1982; Zlotnik and Crowle, 1982) .
Morphologically, a normal resident PlM has prominent intermediate intracytoplasmic filaments and numerous microvilli that may be involved in the adherence to the pleural surfaces (Baumann et al., 1993) . From assessment of the uptake of latex beads, the phagocytic capacity of the PlMs is lower than that of the bronchoalveolar mononuclear phagocytes (BAMP) (that comprise of the BMs and the PSMs) and when cultured together with autologous pulmonary interstitial DCs, PlMs exert a more potent ability to stimulate Tcell proliferation than the BAMPs (Gjomarkaj et al., 1999) . Compared to the BAMPs, PlMs are less portent bactericidal and fungicidal cells (Gjomarkaj et al., 1999) : functionally and phenotypically PlMs are different from the BAMPs and are similar to the peritoneal macrophages. PlMs play an important role in cell-mediated immune reactions in the pleural space (Gjomarkaj et al., 1999) . Compared to the blood monocytes, PlMs seem to represent a cell-type intermediate between the regular CD-14(++) monocytes and the CD-14(+)CD-16(+) subset (Frankenberger et al., 2000) . PlMs perform efficient Fc-receptor-mediated phagocytosis of antibody-coated sheep red blood cells and can inhibit apoptosis of malignant cells (Kaczmarek et al., 2008) .
Pulmonary intravascular macrophages (PIVMs)
For the reasons that the PIMs are lacking in the lungs of most laboratory animals (e.g. Warner and Brain 1990; Warner, 1996; Brain et al., 1999) and since they are relatively less accessible for experimentation, the cells have not been as well-studied as the PSMs. Regarding their secretory, endolytic, and functional properties, PIVMs are a relatively newly identified constituent of the mononuclear phagocyte system. To date, for still unclear reasons, PIVMs have been reported mainly in the domestic mammals, especially in ruminant species like cattle, horse, goat, sheep, and pigs (e.g. Rybicka et al., 1974; Warner and Brain, 1984; Atwal and Saldanha, 1985; Wheeldon and Hansen-Flaschen, 1986; Winkler, 1988 Winkler, , 1989 Atwal et al., 1989 Atwal et al., , 1992 Warner and Brain, 1990; Longworth et al., 1994; Warner, 1996; Parbhakar et al., 2005; Molina and Brain, 2007) and in birds (Maina and Cowley, 1998) (Fig. 36) . It is uncertain whether PIVMs occur in the human lung: while the cells were reported by Dehring and Wismar (1989) , a comprehensive morphometric study of the human lung by Zeltner et al. (1987) didn't report macrophage or macrophagelike cells in the pulmonary capillaries. Particle uptake studies suggested that PIVMs may not exist in the human lung (e.g. Brain et al., 1999) .
The PIVMs have distinctive morphological features of differentiated macrophages like irregular shape, a bean-shaped nucleus, abundant lysosomal bodies, numerous mitochondria, profuse rough endoplasmic reticulum, fuzzy glycocalyx, phagosomes, and pseudopods (e.g. Wheeldon and Hansen-Flaschen, 1986; Cheville, 1985, 1987) . They have an electron dense coat that appears to be predominantly lipoproteinaceous in nature (Atwal et al., 1989) . PIVMs form membrane adhesion complexes with the endothelial cells Winkler and Cheville, 1987) and tend to attach onto the thicker parts of the BGB (Winkler, 1988; Winkler and Cheville, 1987) , probably minimizing interference with gas exchange (by thickening the BGB) which occurs mostly across the thin parts. Moreover, it is possible that the thicker parts of the BGB provide better support than the thinner ones, preventing the cells from being easily dislodged by flowing blood. PIVMs are large in size (20 to 80 μm in diameter), are closely apposed to the endothelium of the pulmonary blood capillaries (Wheeldon and Hansen-Flaschen, 1986; Brain et al., 1999) , and are abundantly endowed with organelles like vesicles, endosomes, and Golgi apparatus (e.g. Atwal et al., 1992) (Fig. 36) . The PIVMs form an important part of the defence of the vertebrate lung. In the pig, perinatally, in a process that is completed by the 7 th day of birth, blood monocytes colonize the lung, replicate within the blood capillaries, and attach to the endothelium by intercellular junctions as they differentiate (Winkler and Cheville, 1985) . By actively synthesizing, storing, and secreting vasoactive substances, PIVMs stimulate biosynthetic pathways that lead to secretion of inflammatory mediators which compound certain disease processes (e.g. Kelly, 1990) . They actively remove particles, bacteria, and endotoxins from circulating blood (Wheeldon and Hansen-Flaschen, 1986; Winkler, 1989; Brain et al., 1999) . While in dogs, laboratory animals, and human beings, clearance of bacteria and particulates from blood occurs mainly in the Kupffer cells of the liver and the splenic macrophages, in calves, sheep, goats, cats, and pigs, the process is performed by the PIVMs (e.g. Warner et al., 1987; Winkler, 1988; Brain et al., 1999) . In the sheep lung, PIVMs form 15.3% of the intravascular volume, attach onto 7.1% of the endothelial surface, and have 15.9 m 2 of their free surface available for contact with blood . Even in normal (steady-state) sheep lungs, there are more macrophages in their vast pulmonary blood vessels than on their alveolar surface and compared to the PSMs the PIVMs are relatively more actively phagocytic . In the deer, PIVMs are more than twice the number of PSMs but PIVMs are much smaller (47.625m 2 ) than the PSMs (101.260m 2 ) (Carrasco et al., 1996) .
The PIVMs have been implicated in the vascular inflammation that results in lipopolysaccharide (LPS)-induced lung inflammation and endotoxemia in the horse (Aharonson-Raz and Singh, 2010), rat (Gill et al., 2008) , and sheep (Warner et al., , 1987 and with the oedema that occurs in the horse after infection with the African horse sickness virus (Carrasco et al., 1999) . While in the newborn pig clearance of blood-borne bacteria (as well as carbon) is only ~10% of the injected dose (Mouton et al., 1963) , in pigs of 15 to 20 kg body mass (~20-month old), 75% of intravenously infused bacteria (depending on species of bacteria) are cleared in the lungs (Wismar et al., 1984; Dehring et al., 1983) . PIVMs play a significant role in regulating pulmonary blood flow, i.e., hemodynamics (e.g. Winkler 1989 ): stimulation of phagocytosis causes the PIVMs to increase in size thus narrowing or blocking the lumina of blood vessels (Winkler and Cheville, 1985) . In pigs as well as calves and sheep, this increases resistance to blood flow, leading to pulmonary hypertension (Tucker et al., 1975; Atwal et al., 1989) and pulmonary oedema (Niehaus et al., 1980) . Bovine PIVMs contain TNF-(tumour necrotic factor) and their depletion significantly inhibits accumulation of inflammatory cells and pathology in acute lung disease in calves (Singh et al., 2004) . In ruminants, PIVMs are involved in lipid metabolism and are the major source of vasoactive substances which significantly influence the dynamics of pulmonary circulation and surfactant turn over in the type-2 cells (Atwal et al., 1989) .
Conclusion and future directions
Although substantial progress has been made in understanding the physical and functional phenotypes of macrophages in the lung, the knowledge remains scanty. This is evinced by lack of significant breakthroughs in the management and treatment of diseases like acute respiratory distress syndrome (ARDS). Furthermore, the specific functions performed by the different pulmonary macrophage lineages and the manner in which these cells communicate remain unclear.
Animals have evolved in close association with microorganisms some of which are harmful: intense selective pressure by the pathogens on the animal hosts and vice-versa has and continues to happen. In a critical encounter, when a pathogen contacts a host, a struggle between it and the host ensues. The outcome is infection and blatant disease or the pathogen is neutralized and eliminated. Successful microbial pathogens have been adept in developing means and strategies of evading the host defences while successful hosts have developed novel defence systems. Understanding the underpinnings behind the evolution of microbial pathogenicity and the intricate ways that animals counteract pathogens is vital in designing strategies of controlling microbial infection and stopping disease progression. Few other organs in the body are as well-and strategically protected as the lung: a cellular defence arsenal exists. From outside to inside are the pleural-, the intravascular, the interstitial-, and the surface (free) macrophages and along the airways (bronchi) are the bronchial macrophages, the dendritic cells, and the epithelial cells. This intricate level of protection has mainly developed because of the vast respiratory surface area that is constantly ventilated with air (which depending on locality contains harmful particulates and pathogenic microorganisms) and the fact that the lung is the only organ in the body which is perfused by the entire cardiac output, a feature that places it at greater risk from blood borne injurious agents. The biology of phagocytes and antigen presenting cells should provide insights on the pathogenesis of pulmonary diseases and may explain why some diseases, including the zoonotic ones, affect certain animal species and groups and not others. Important as it is, the area of comparative immunology offers much to be investigated.
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